LEIDOS AUSTRALIA SIGNS MOU WITH UNSW

University of NSW (UNSW) and Leidos Australia have signed a Memorandum of Understanding (MOU) to collaborate on research and development in the fields of force protection and biological security

28th Nov 2017


LEIDOS AUSTRALIA SIGNS MOU WITH UNSW

SYDNEY, Australia, 28 November, 2017 –University of NSW (UNSW) and Leidos Australia have signed a Memorandum of Understanding (MOU) to collaborate on research and development in the fields of force protection and biological security for the Australian Defence Force (ADF).

Due to increasing political instability and rising global tension, the threat of unconventional attacks has substantially increased. This partnership will support improvements in detection and response to mitigate the threat of biological, chemical, and radiological weapons for the Australian people and our allies.

The broader application of this research will help first responders handle hazmat situations like industrial chemical releases and drug labs more effectively, as well as help Australian health officials respond more effectively to emergent diseases like Avian Flu, Tuberculosis, MERS, and antibiotic resistance.

The MOU was signed by UNSW Head of School, School of Public Health and Community Medicine Professor Raina MacIntyre and Leidos Australia Technical Director, Dan Brewer.

 

Professor Raina MacIntyre said, “We welcome this MOU and investment from Leidos Australia. This sort of collaboration between industry and academia is very important because it enables us to find new ways to solve problems together.”

Leidos Australia Technical Director, Dan Brewer said. “Leidos Australia’s investment in dual-use technologies such as these represents our continued commitment to both the safety and security of the ADF and the Australian people as a whole.”

 

Media Contacts:
Simon Carr – Leidos-Australia-Communications@leidos.com

For more information, visit www.leidos.com/australia

 

About Leidos
Leidos is a Fortune 500® science and technology solutions and services leader working to solve the world’s toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company’s 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $7.04 billion for the fiscal year ended December 30, 2016. For more information, visit www.Leidos.com.

###

Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company’s Annual Report on Form 10-K for the period ended December 30, 2016, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.

 

 

APDR at a glance